Bellevue, Washington Clinical Trials

*Healthy Children Studies

Northwest Clinical Research Center New

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Angina

Research Site Updated

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Arthritis and Arthritic Pain

Research Site

Osteoarthritis Research Studies

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

Northwest Clinical Research Center New

A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with Attention Deficit-Hyperactivity Disorder (ADHD)

Autism

Northwest Clinical Research Center New

A PHASE II MULTI-CENTER, RANDOMIZED, DOUBLEBLIND, 24-WEEK, 3-ARM, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RO5285119 IN CHILDREN AND ADOLESCENTS AGE 5-17 WITH AUTISM SPECTRUM DISORDER (ASD)

Bipolar Disorder

Northwest Clinical Research Center New

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION

Breast Cancer

Overlake Medical Center

A clinical trial to evaluate treatments using BLZ-100 for patients with Solid Tumors

Chronic Back Pain

Northwest Clinical Research Center New

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Chronic Pain

Northwest Clinical Research Center New

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

View More »

Northwest Clinical Research Center Updated

A clinical trial to evaluate treatments for patients with Low Back Pain, Chronic

Northwest Clinical Research Center Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Colorectal Cancer

Overlake Medical Center

A clinical trial to evaluate treatments using BLZ-100 for patients with Solid Tumors

Constipation

Northwest Clinicial Research Center

A clinical research study of Lubiprostone and Placebo for the treatment of Constipation - Functional

Northwest Clinicial Research Center

A clinical trial seeking patients for a research study for the treatment of Constipation - Functional

Synergy Pharmaceuticals Inc.

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

COPD (Chronic Obstructive Pulmonary Disease)

Northwest Clinical Research Center New

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®, as an Active Control, on Lung Function over a 24-Week Treatment Period in Subjects With Moderate to Very Severe COPD

View More »

Research Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Depression

MMG

Does Your Child Have Depression?

View More »

Alkermes Investigational Site

A clinical trial seeking patients for a research study for the treatment of Major Depressive Disorder (MDD)

Forest Investigative Site 001

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Investigative Site 001

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study evaluating onabotulinumtoxinA and Normal Saline for the treatment of Depressive Disorder, Major

Northwest Clinical Research Center

Patients are needed to participate in a clinical research study evaluating CERC-301 and Placebo for the treatment of Major Depressive Disorder (MDD)

Depression (Adolescent)

MMG

Does Your Child Have Depression?

Northwest Clinical Research Center New

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Depression (Major/Severe)

MMG

Does Your Child Have Depression?

Depression (Pediatric)

Northwest Clinical Research Center New

A Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder

Depression (Treatment-Resistant)

Northwest Clinical Research Center New

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Northwest Clinical Research Center New

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Diabetes (Pediatric)

Northwest Clinical Research Center New

A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Call for Information (Investigational Site 2328) Updated

A clinical trial to evaluate treatments for patients with Type 2 Diabetes Mellitus

Investigational Site Number 8400093 Updated

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Fibromyalgia

Northwest Clinical Research Center New

A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SAFETY STUDY OF DS-5565 FOR TREATMENT OF PAIN DUE TO FIBROMYALGIA IN SUBJECTS WITH CHRONIC KIDNEY DISEASE

View More »

Research Site

Patients are needed to participate in a clinical research study to evaluate Pain Associated With Fibromyalgia

Glaucoma

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Specialty Eye Care

A clinical trial to evaluate treatments using Glaucoma Surgery and InnFocus MicroShunt for patients with Primary Open Angle Glaucoma

Heart Disease

Research Site Updated

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hemodialysis

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Hemorrhage

Lake Washington Vascular

A clinical research study of CELSTAT and Surgicel Original for the treatment of Bleeding Active

High Blood Pressure (Hypertension)

Northwest Clinical Research Center New

Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential hypertension (grade 1 and 2)

View More »

Northwest Clinical Research Center Updated

Patients are needed to participate in a clinical research study of Endothelin Receptor Antagonist (ERA), Lisinopril and Placebo to evaluate Essential Hypertension

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Inflammatory Bowel Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Kidney Disease

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Lung Cancer

Overlake Medical Center

A clinical trial to evaluate treatments using BLZ-100 for patients with Solid Tumors

Lymphocytic Leukemia, Chronic

Swedish - Bellevue

Clinical trial for Patients with Chronic Lymphocytic Leukemia

Macular Degeneration

Research Site

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Research Site

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Research Site

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Vitreoretinal Associates of Washington

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Migraine and Cluster Headaches

Northwest Clinical Research Center New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Chronic Migraine – the REGAIN Study

Northwest Clinical Research Center New

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Northwest Clinical Research Center New

A Parallel Group Double-Blind Randomized Placebo Controlled Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Frequent Episodic Migraines

Northwest Clinical Research Center New

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE

Neoplasm Metastasis

1160.189.10237 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Ocular Hypertension

Speciality Eyecare Centre

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Osteoarthritis

Northwest Clinical Research Center New

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Northwest Clinical Research Center New

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Research Site

Osteoarthritis Research Studies

View More »

Northwest Clinical Research Center Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center Updated

A clinical trial to evaluate treatments using Placebo, Tanezumab 2.5 mg and Tanezumab 2.5mg/5mg for patients with Osteoarthritis, Knee or Osteoarthritis, Hip

Pain

Northwest Clinical Research Center New

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Northwest Clinical Research Center New

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

View More »

Research Site

Patients are needed to participate in a clinical research study to evaluate Pain Associated With Fibromyalgia

Postherpetic Neuralgia

Northwest Clinical Research Center New

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (4% and 8% w/w Ointment) in Patients with Postherpetic Neuralgia

View More »

Teva Investigational Site 13081

A clinical trial to evaluate treatments using TV-45070 and Placebo for patients with Postherpetic Neuralgia (PHN)

Prostate Cancer

Overlake Medical Center

A clinical trial to evaluate treatments using BLZ-100 for patients with Solid Tumors

Schizophrenia and Schizoaffective Disorders

Northwest Clinical Research Center New

A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults with Schizophrenia

Northwest Clinical Research Center New

A phase II randomised, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with Schizophrenia

Northwest Clinical Research Center New

A 12 WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-04958242 IN SUBJECTS WITH COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA (CIAS)

Solid Tumors

Overlake Medical Center

A clinical trial to evaluate treatments using BLZ-100 for patients with Solid Tumors

Stroke

Research Site Updated

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

1160.189.10237 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Ulcerative Colitis

Research Site

A Phase 3 clinical study for patients with Ulcerative Colitis

Research Site

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Ulcers

Research Site

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Research Site

A Phase 3 clinical study for patients with Ulcerative Colitis